मुंह का कैंसर
This study involved people with oral cancer and looked at how well a new saliva-based testing device could tell if their treatment was working, if the cancer might come back, and how well they were recovering compared to the usual methods like biopsies and medical scans.
हॉस्पिटल से संपर्क करें
रजिस्ट्री में इस hospital को trial के main contact के तौर पर दिखाया गया है। उनसे पूछिए कि कौन-कौन से hospital मरीज़ों को ले रहे हैं।
रजिस्ट्री समरी (तकनीकी)
A Prospective, Multi-Centre, Performance Evaluation Study to Determine the Accuracy of Saliscope, A Saliva Based Companion Diagnostic Assay in Predicting Chemotherapeutic Response, Relapse Propensity and Immunotherapeutic Efficacy in Oral Squamous Cell Carcinoma Patients, in Comparison to Conventional Histopathology Evaluation and RECIST Guidelines - NIL
Sponsor: Genoscope Private Limited
CTRI, भारत की trial registry पर CTRI/2026/06/112560
Source: Clinical Trials Registry – India (CTRI), WHO ICTRP के ज़रिए, डेटा 12 Oct 2026
रजिस्ट्री में आखिरी अपडेट 5 Oct 2026 · हमने 5 Nov 2026 को पढ़ा